Literature DB >> 20009421

Evaluation of prognostic factors and establishment of a prognostic scoring system for canine primary immune-mediated hemolytic anemia.

Masahiro Ishihara1, Yasuhito Fujino, Asuka Setoguchi, Masashi Takahashi, Ko Nakashima, Koichi Ohno, Hajime Tsujimoto.   

Abstract

Clinical courses of primary immune-mediated hemolytic anemia (pIMHA) in dogs are highly variable, however, limited information is available to predict their accurate prognoses. To evaluate the prognostic significance of clinical factors and to propose a scoring system to predict prognoses, the medical records of seventy-one dogs with pIMHA were reviewed. Overall mortality rate of dogs with pIMHA was 39% and most of the dogs died within 3 months from diagnosis. Sex, body weight, seasonality, packed corpuscular volume (PCV), platelet count (PLT), total plasma protein (TP), blood urea nitrogen, albumin, total bilirubin, sodium ion, prothrombin time, and fibrin/fibrinogen degradation products before immunosuppressive treatment can influence on survival time in dogs with pIMHA. A prognostic scoring system using a combination of sex, seasonality, PCV, PLT and TP can be statistically significant for raising the accuracy of prognostic prediction. Using the scoring system for prognostication in dogs with pIMHA may enable veterinarians to predict a prognosis easily and accurately.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009421     DOI: 10.1292/jvms.09-0283

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

1.  Utility and prognostic significance of leukocyte ratios in dogs with Primary Immune-Mediated Hemolytic Anemia.

Authors:  Chiara Alaimo; Giulia De Feo; George Lubas; Alessandra Gavazza
Journal:  Vet Res Commun       Date:  2022-05-13       Impact factor: 2.459

Review 2.  Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia.

Authors:  J W Swann; B J Skelly
Journal:  J Vet Intern Med       Date:  2015-01-13       Impact factor: 3.333

3.  Predicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case Registry.

Authors:  R Goggs; S G Dennis; A Di Bella; K R Humm; G McLauchlan; C Mooney; A Ridyard; S Tappin; D Walker; S Warman; N T Whitley; D C Brodbelt; D L Chan
Journal:  J Vet Intern Med       Date:  2015-10-16       Impact factor: 3.333

Review 4.  Canine autoimmune hemolytic anemia: management challenges.

Authors:  James W Swann; Barbara J Skelly
Journal:  Vet Med (Auckl)       Date:  2016-07-26

5.  ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.

Authors:  Oliver A Garden; Linda Kidd; Angela M Mexas; Yu-Mei Chang; Unity Jeffery; Shauna L Blois; Jonathan E Fogle; Amy L MacNeill; George Lubas; Adam Birkenheuer; Simona Buoncompagni; Julien R S Dandrieux; Antonio Di Loria; Claire L Fellman; Barbara Glanemann; Robert Goggs; Jennifer L Granick; Dana N LeVine; Claire R Sharp; Saralyn Smith-Carr; James W Swann; Balazs Szladovits
Journal:  J Vet Intern Med       Date:  2019-02-26       Impact factor: 3.333

6.  Evaluation of membrane-based therapeutic plasma exchange as adjunctive treatment for immune-mediated hematologic disorders in dogs.

Authors:  Thierry Francey; Mathieu Etter; Ariane Schweighauser
Journal:  J Vet Intern Med       Date:  2021-02-11       Impact factor: 3.333

7.  Breed predispositions, clinical findings, and prognostic factors for death in dogs with nonregenerative immune-mediated anemia.

Authors:  Vanessa L Woolhead; Balazs Szladovits; Antonia Chan; James W Swann; Barbara Glanemann
Journal:  J Vet Intern Med       Date:  2020-12-08       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.